ArticleScientific reports2019
HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic.
Open access · goldAbstract read
In one paragraph
Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 20 citations in OpenAlex.
- TARDBP as a regulator of HIV-1 assembly and infection: a review of targeting the viral capsid precursor Pr55Gag and limiting viral core entry.Cell communication and signaling : CCS · 2026Review
- Viremic non-progression in HIV/SIV infection: A tied game between virus and host.Cell reports. Medicine · 2025Review
- Bafilomycin A1 Inhibits HIV-1 Infection by Disrupting Lysosomal Cholesterol Transport.Viruses · 2024Article
- Article
- HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton.International journal of molecular sciences · 2023Review
- Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1.International journal of molecular sciences · 2023Review
- TDP-43 Controls HIV-1 Viral Production and Virus Infectiveness.International journal of molecular sciences · 2023Article
- Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.Biomedicines · 2022Review
- Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6.International journal of molecular sciences · 2022Article
- Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo.Scientific reports · 2022Article
- Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.Journal of virology · 2022Article
- The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis.Frontiers in microbiology · 2022Article
- The Interplay of HIV and Autophagy in Early Infection.Frontiers in microbiology · 2021Review
- A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.Journal of virology · 2020Article
- Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection.Frontiers in immunology · 2020Article
- HIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection.Frontiers in microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 5 institutions in 2 countries.
Romina Cabrera-RodríguezLaboratorio de Inmunología Celular y Viral, Unidad Virología y Microbiología del IUETSPC, Unidad de Farmacología, Sección de Medicina, Facultad de Medicina, Universidad de La Laguna (ULL), La Laguna, 38071, Tenerife, Spain.
Veronique HebmannInstitut de Recherche en Infectologie de Montpellier (IRIM), Université de Montpellier, CNRS, 34293, Montpellier, France.
Silvia MarfilAIDS Research Institute IrsiCaixa, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), 08916 Badalona, Barcelona, Catalonia, Spain.
María PernasUnidad de Virología Molecular. LRIR. Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.
Sara Marrero-HernándezLaboratorio de Inmunología Celular y Viral, Unidad Virología y Microbiología del IUETSPC, Unidad de Farmacología, Sección de Medicina, Facultad de Medicina, Universidad de La Laguna (ULL), La Laguna, 38071, Tenerife, Spain.
Cecilia CabreraAIDS Research Institute IrsiCaixa, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), 08916 Badalona, Barcelona, Catalonia, Spain.ORCID http://orcid.org/0000-0002-9941-6828
Victor UrreaAIDS Research Institute IrsiCaixa, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), 08916 Badalona, Barcelona, Catalonia, Spain.ORCID http://orcid.org/0000-0002-2577-856X
Concepción CasadoUnidad de Virología Molecular. LRIR. Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.
Isabel OlivaresUnidad de Virología Molecular. LRIR. Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.
Daniel Márquez-ArceLaboratorio de Inmunología Celular y Viral, Unidad Virología y Microbiología del IUETSPC, Unidad de Farmacología, Sección de Medicina, Facultad de Medicina, Universidad de La Laguna (ULL), La Laguna, 38071, Tenerife, Spain.
Silvia Pérez-YanesLaboratorio de Inmunología Celular y Viral, Unidad Virología y Microbiología del IUETSPC, Unidad de Farmacología, Sección de Medicina, Facultad de Medicina, Universidad de La Laguna (ULL), La Laguna, 38071, Tenerife, Spain.
Judith Estévez-HerreraLaboratorio de Inmunología Celular y Viral, Unidad Virología y Microbiología del IUETSPC, Unidad de Farmacología, Sección de Medicina, Facultad de Medicina, Universidad de La Laguna (ULL), La Laguna, 38071, Tenerife, Spain.
Bonaventura ClotetAIDS Research Institute IrsiCaixa, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), 08916 Badalona, Barcelona, Catalonia, Spain.
Lucile EspertInstitut de Recherche en Infectologie de Montpellier (IRIM), Université de Montpellier, CNRS, 34293, Montpellier, France.
Cecilio López-GalíndezUnidad de Virología Molecular. LRIR. Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.
Martine Biard-PiechaczykInstitut de Recherche en Infectologie de Montpellier (IRIM), Université de Montpellier, CNRS, 34293, Montpellier, France.
Agustín Valenzuela-FernándezLaboratorio de Inmunología Celular y Viral, Unidad Virología y Microbiología del IUETSPC, Unidad de Farmacología, Sección de Medicina, Facultad de Medicina, Universidad de La Laguna (ULL), La Laguna, 38071, Tenerife, Spain. avalenzu@ull.edu.es.ORCID http://orcid.org/0000-0002-2585-8703
Julià BlancoAIDS Research Institute IrsiCaixa, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), 08916 Badalona, Barcelona, Catalonia, Spain. jblanco@irsicaixa.es.ORCID http://orcid.org/0000-0002-2225-0217
Universidad de La Laguna · ESInstituto de Salud Carlos III · ESCentre National de la Recherche Scientifique · FRIrsiCaixa · ESUniversitat de Vic - Universitat Central de Catalunya · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
In untreated HIV-1-infected individuals, viremia is positively associated with disease progression. However, some viremic non progressors (VNPs) individuals show paradoxical high CD4
Indexed as
AutophagyCD4 AntigensCD4-Positive T-Lymphocytesenv Gene Products, Human Immunodeficiency VirusGene Expression Regulation, ViralHEK293 CellsHIV-1HIV InfectionsHumansViremiaVirus ReplicationCD4 Antigensenv Gene Products, Human Immunodeficiency Virus
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.